DA32 Life Science Tech Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.
IPO Year: 2021
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - DA32 Life Science Tech Acquisition Corp. (0001863294) (Issuer)
4 - DA32 Life Science Tech Acquisition Corp. (0001863294) (Issuer)
4 - DA32 Life Science Tech Acquisition Corp. (0001863294) (Issuer)
4 - DA32 Life Science Tech Acquisition Corp. (0001863294) (Issuer)
4 - DA32 Life Science Tech Acquisition Corp. (0001863294) (Issuer)
4 - DA32 Life Science Tech Acquisition Corp. (0001863294) (Issuer)
4 - DA32 Life Science Tech Acquisition Corp. (0001863294) (Issuer)
4 - DA32 Life Science Tech Acquisition Corp. (0001863294) (Issuer)
4 - DA32 Life Science Tech Acquisition Corp. (0001863294) (Issuer)
Fastest customizable press release news feed in the world
DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS) today announced that its board of directors (the "Board") has determined to redeem all of its outstanding shares of Class A common stock (the "Public Shares"), effective as of July 28, 2023, because the Company will not consummate an initial business combination within the time period required by its amended and restated certificate of incorporation. As of the close of business on July 28, 2023, the Public Shares will be deemed cancelled and will represent only the rights to receive the per-share redemption price of approximately $10.31 (after taking into account the removal of a portion of the accrued interest in the trust account to
15-12G - DA32 Life Science Tech Acquisition Corp. (0001863294) (Filer)
25-NSE - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
8-K - DA32 Life Science Tech Acquisition Corp. (0001863294) (Filer)
10-Q - DA32 Life Science Tech Acquisition Corp. (0001863294) (Filer)
10-K - DA32 Life Science Tech Acquisition Corp. (0001863294) (Filer)
10-Q - DA32 Life Science Tech Acquisition Corp. (0001863294) (Filer)
10-Q - DA32 Life Science Tech Acquisition Corp. (0001863294) (Filer)
10-Q - DA32 Life Science Tech Acquisition Corp. (0001863294) (Filer)
10-K - DA32 Life Science Tech Acquisition Corp. (0001863294) (Filer)
10-Q - DA32 Life Science Tech Acquisition Corp. (0001863294) (Filer)
This live feed shows all institutional transactions in real time.
SC 13G/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
SC 13G/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
SC 13G/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
SC 13D/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
SC 13D/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
SC 13D/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
SC 13D/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
SC 13G/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
SC 13G - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)
SC 13G/A - DA32 Life Science Tech Acquisition Corp. (0001863294) (Subject)